Szerző: " Hohnloser Stefan H."

Vámos Máté; Zsigmond Előd-János; Hohnloser Stefan H.: Indications for mexiletine in the new ESC guidelines and beyond.
EXPERT OPINION ON PHARMACOTHERAPY, 24 (12). 1403 -1407. ISSN 1465-6566 (2023)

Kattih Badder; Operhalski Felix; Boeckling Felicitas; Hecker Florian; Michael Felix; Vámos Máté; Hohnloser Stefan H.; Erath Julia W.: Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort.
FRONTIERS IN CARDIOVASCULAR MEDICINE, 9. ISSN 2297-055X (2022)

Vámos Máté; Oldgren Jonas; Nam Gi-Byoung; Lip Gregory Y. H.; Calkins Hugh; Zhu Jun; Ueng Kwo-Chang; Ludwigs Ulf; Wieloch Mattias; Stewart John; Hohnloser Stefan H.: Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial.
EUROPEAN HEART JOURNAL - CARDIOVASCULAR PHARMACOTHERAPY, 8 (4). pp. 363-371. ISSN 2055-6837 (2022)

Ernst Matthias; Sághy László; Hohnloser Stefan H.; Vámos Máté: Avoiding ICD lead revision in a patient with chronically low R-wave amplitudes.
CARDIOLOGIA HUNGARICA, 50 (3). pp. 199-201. ISSN 0133-5596 (2020)

Vámos Máté; Hugh Calkins; Kowey Peter R.; Torp-Pedersen Christian T.; Genti Valerie Corp Dit; Wieloch Mattias; Koren Andrew; Hohnloser Stefan H.: Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter : Insights from the ATHENA study.
CLINICAL CARDIOLOGY, 43 (3). pp. 291-297. ISSN 0160-9289 (2020)

Biliczki Péter; Boon Reinier A.; Girmatsion Zenawit; Bukowska Alicia; Ördög Balázs; Kaess Bernhard M.; Hohnloser Stefan H.; Goette Andreas; Varró András; Moritz Anton; Nattel Stanley; Ehrlich Joachim R.: Age-related regulation and region-specific distribution of ion channel subunits promoting atrial fibrillation in human left and right atria.
EUROPACE, 21 (8). pp. 1261-1269. ISSN 1099-5129 (2019)